Taranabant
-
Merck halts development of taranabant for obesity
Merck & Co says it will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III data showed that …
Taranabant | 13 October 2008
